Director National Accounts Employer Intellia Therapeutics Location Cambridge, MA Start date Sep 12, 2026 View more categories View less categories Discipline Sales & Service , Account Management Required Education Bachelors Degree Position Type Full time Hotbed Genetown , Best Places to Work Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We wantall ofour people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just "treat" people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together. The National Account Director - Commercial Payers will play a critical leadership role in shaping and executing our U.S. market access strategy with national and large regional commercial payers in preparation for our first gene editing therapy launch. This is a high-impact, field-based position responsible for building relationships with key payer stakeholders, communicating product value, and securing favorable coverage and reimbursement pathways. This is a highly strategic, hands-on role that is ideal for an experienced national account professional who thrives in fast-paced, build-from-scratch environments and understands the complexity of launching innovative, high-value therapies.

Duties/Responsibilities Responsibilities:

Lead strategic engagement with national and large regional commercial payers (e.g.,CVS, Zinc,Aetna,Synergie/Elevance, Kaiser,Regional Blues Plans,etc.). Build and manage relationships with key decision-makers across payer organizations. Analyze the competitive landscape and coverage policies toanticipatepayer needs and barriers. Develop and execute early account engagement plans in anticipation of launch, educating payer stakeholders on gene editing science, disease burden, andanticipatedvalue proposition. Partner with internal teams (Market Access Strategy, Contracts and Pricing, HEOR, Medical Affairs, Clinical, Regulatory) to develop and tailor payer-facing materials, including early scientific exchange, evidence dossiers, PIE presentations, and budget impact models. Drive payer insight generation to inform pricing strategy, contracting models, and patient access programs in pre-launch and launch phases. Collaborate with internal launch team to support pull-through planning, distribution strategy, and affordability/access solutions. If required,identify, shape, and lead negotiation of value-based or outcomes-based contracting opportunities aligned with Intellia, product profile, and payer priorities. Monitor and influence payer policy development relevant to gene editing and high-cost cell & gene therapies. Serve as the internal voice of the payer andprovidestrategic guidance to senior leadership oncoveragerisks, opportunities, and commercial landscape dynamics. Ensure all engagements and materials are fully compliant with legal, regulatory, and corporate standards. Cross-Functional Integration & Collaboration Serve as a key commercial liaison across internal stakeholders, including Market Access Leadership, Medical Affairs, Marketing, Patient Services, Finance, and Regulatory, to ensure alignment on strategic initiatives and execution plans that support national accountobjectives. Partner closely with Field Market Access, Trade, and Channel teams to co-develop and deliver integrated account strategies that enhance access, affordability, and distribution of gene therapy products across national payers, PBMs, IDNs, and specialty pharmacies. Lead cross-functional account planning sessions to synthesize market insights,anticipatecustomer needs, and develop tailored engagement models that driveoptimaltherapeutic adoption and long-term value creation. Collaborate with clinical and HEOR teams to translate complex scientific and economic value propositions into compelling narratives for diverse payer stakeholders. Facilitate seamless internal coordination and communication to ensure the delivery of compliant, consistent messaging and solutions that reflect both the scientific innovation and commercial strategy of the organization. Drive organizational readiness and pull-through efforts across functionalteamspre- and post-launch to ensure market access success in a highly regulated and evolving gene therapy landscape. Success Metrics Achievement of targeted payer coverage milestones and KPIs Breadth and depth of payer access across account Execution of value-based contracting, ifrequired Internal alignment and readiness to support access and alignment efforts Supervisory Responsibilities Requirements Skills/Abilities About you: Proventrack recordof managing national commercial payer accounts, including pre-launch and launch readiness for specialty or rare disease products. Experience with innovative reimbursement models, especially value-based or indication-based contracting. Strong grasp of payer decision-making processes, formulary management, medical policy development, and specialty pharmacy dynamics. Demonstrated ability to thrive in early-stage or launch environments,operatingwith agility and strategic foresight. Excellent communicator who can convey complex scientific and economic data to non-scientific audiences. Strong project management and cross-functional leadership skills. Excellent negotiation skills and analytical capabilities. Comfortable operating in ambiguity with a strong bias for action and accountability.

Travel:

Up to 50%, including partner meetings, conferences, and internal cross-functional workshops.

Education / Certifications

Bachelor's degreerequired; MBA or other graduate degree preferred. 8+ years of pharmaceutical or biotech market access experience, payer account management, or managedmarketsstrategy. #

LI-KO1 EEOC

Statement:

Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down. The base salary for this position is expected to range between $243,000.00 - $297,000.00 USD per year. The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors. Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company's discretion. For more information about Intellia's benefits, please click here . Company Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers. Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously. We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases. Change life stories with genome editing therapies!

Stock Symbol:

NTLA Company info Website http://intelliatx.com/ Phone (857) 285-6200 Location 400 Technology Square Suite 100 Cambridge Massachusetts 02139 United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert Similar jobs Area Business Manager, Pulmonary Brooklyn, NY Working from Home Account Manager, Ophthalmology Overlay- Tampa, FL Tampa, Florida Cardiovascular Key Account Manager, Dallas, TX Dallas, Texas